The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 23,627 | 3,905,225 | SH | SOLE | 3,905,225 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 88,349 | 8,218,467 | SH | SOLE | 8,218,467 | 0 | 0 | ||
| ISHARES TR | S&P 500 VAL ETF | 464287408 | 7,241 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | ||
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 382,035 | 10,918,393 | SH | SOLE | 10,918,393 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 94,902 | 2,896,901 | SH | SOLE | 2,896,901 | 0 | 0 | ||